Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Carlyle (CGABL) Current Deferred Revenue (2016 - 2025)

Carlyle has reported Current Deferred Revenue over the past 15 years, most recently at $129.2 million for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $129.2 million for Q4 2025, down 6.85% from a year ago — trailing twelve months through Dec 2025 was $129.2 million (down 6.85% YoY), and the annual figure for FY2025 was $129.2 million, down 6.85%.
  • Current Deferred Revenue for Q4 2025 was $129.2 million at Carlyle, down from $373.0 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for CGABL hit a ceiling of $421.5 million in Q1 2025 and a floor of $104.8 million in Q2 2022.
  • Median Current Deferred Revenue over the past 5 years was $269.0 million (2021), compared with a mean of $259.3 million.
  • Biggest five-year swings in Current Deferred Revenue: soared 138.57% in 2021 and later dropped 14.87% in 2022.
  • Carlyle's Current Deferred Revenue stood at $120.8 million in 2021, then rose by 4.64% to $126.4 million in 2022, then rose by 11.0% to $140.3 million in 2023, then decreased by 1.14% to $138.7 million in 2024, then decreased by 6.85% to $129.2 million in 2025.
  • The last three reported values for Current Deferred Revenue were $129.2 million (Q4 2025), $373.0 million (Q3 2025), and $204.0 million (Q2 2025) per Business Quant data.